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having any 'perverse incentives.' Must a new test fulfil
different norms?
The RSSA advocates sole EBCT ownership by
radiologists. Would rearrangement of the present ownership
to that end result in its miraculous acceptance of the
modality? Why did Or Tuft, wearing his Private Practice
Negotiations Committee hat, recommend that 'the following
new item [code 3598] be introduced in the current Tariff
structure with immediate effect' in June 19971 Why, shortly
thereafter, did Or Tuft, wearing his RSSA hat, write to RAMS
saying 'If funds are allocated [to EBCT] we would request
they be not allocated to radiology'? Is this intended to stop
others from utilising the exclusive CT radiology toll road?
Amazingly, the RSSA allows vintage, unroadworthy, lethally
dangerous CT scanners 'with a matrix less than 250' to still
utilise this road, while the latest-model EBCT must drive on
its own pathway, which is landmined with code 3598! Is this
job reservation in the interest of the patient, who must now
pay for this test out of his pocket? What will happen to CT
colonoscopy, CT bronchoscopy and CT angiography? Who
will own MRI-guided operating theatres? Is the RSSA
positioning to have sole ownership of (and profit from) all of
these?
In summary, EBCT represents a quantum leap in
technology In terms of rapid image aquisition. This is of
special importance in the non-invasive early detection of
coronary heart disease. Ideally, patients at risk need a
thorough history and examination performed by any caring,
honest doctor, who will then refer some patients for
coronary artery calcium assessment by EBCT. The additional
value of the calcium score allows the knOWledgeable doctor
the best opportunity to appropriately advise and, if
necessary, cost-effectively administer tailored treatment to
the patie~t. Patients at risk, but having normal stress tests,
are less likely to accept medical advice and comply with
therapy than patients shown radiographs demonstrating the
distribution and extent of visible calcium deposits in their
own arteries. The calcium score and calcium distribution
alteration over time may prove to be a useful yardstick to
monitor coronary artery disease progression.
Continued dependence on inaccurate and misleading
tests, which medical aids pay for, wastes money, while
advising them not to pay for EBCT coronary calcium
assessment shows an irresponsible lack of concern for
patient well-being. Is the patient not between a rock and a
hard place if he or she must pay for this valuable test?
Some new aspects of imaging can no longer be restrained
by the artificial 'turf' compartments of conventional
medicine. The dirty linen of medical issues which may not
have the patient's best interests at heart will surely soon be
washed in well-publicised court cases, seriously damaging
the Image of conventional medicine. There is an urgent need
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Solid science and hard
logic - the rock on which
good treatment is based
With electron beam computed tomography (EBCT) it is now
possible to detect non-invasively and rapidly, and to a
degree to quantify, calcium deposition in coronary arteries.
This remarkable technique also allows for a detailed
evaluation of cardiac function and cardiac chamber volume
and mass, both at rest and during exercise. It is likely that
myocardial blood flow will soon be similarly quantifiable.' We
are therefore excited by the existence of this apparatus in
the Pretoria Heart Hospital. The ability to detect
intracoronary calcium, and implications deriving from the
fact that such deposition only occurs in diseased arteries,
has sparked major controversy in terms of the application of
this technique.
In this issue of the SAMJ Or Nel joins the controversy with
an impassioned appeal for widespread utilisation of EBCT
for existing or suspected coronary artery disease, either
clinically manifest or silent. The sociopolitical parallels he
draws, although poignant, are often somewhat obscure and
bitter, particularly in relation to issues of ownership and
payment. Much of the heat generated in this controversy
relates to appeals made directly to the general public, and is
often centred around the spectre of sudden cardiac death.
Thus the focus is both medical and fiscal.
An excellent, balanced and current overview of the
epidemiology, clinical implications, pathophysiology and
imaging of coronary artery calcification is offered in a
statement from the American Heart Association (AHA), to
which the reader is referred!
EBCT-detected coronary calcification can predict future
cardiac events, but not all of them.' It is a good predictor of
the need for revascularisation in both symptomatic and
asymptomatic3 patients, but a poor predictor of coronary
death or myocardial infarction.' This regrettably partly closes
the 'window of opportunity' optimistically referred to by Or
Nel. The reason for this inability to predict myocardial
infarction and infarction-related death is that although ECBT-
detected coronary calcium correlates well with the
established atherosclerotic plaque that can impair coronary
flow when large (the bigger the plaque the higher the
calcium score), thrombosis and infarction often occur in
unstable plaques lacking or low in calcium. They also occur
frequently in the absence of a heavily calcified overall plaque
load.'" Sudden cardiac death has causes other than acute
myocardial infarction. A major cause is predictable and
treatable ventricular arrhythmias. Here death is preventable
with implantable defibrillators, a fact proven in numerous
studies, but payment for the implantation has not been
guaranteed by the Representative Association for Medical
Schemes (RAMS).
There is an overall correlation between the total area of
detected coronary calcification and the total plaque load!"o
Unfortunately there is currently insufficent evidence that
EBCT can accurately track the total atherosclerotic load
over time. It therefore cannot act as a guide to whether
therapy is effective nor not. Although this may improve with
new technology, it has not been proved as yet.
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In symptomatic patients with angina, EBCT is powerfully
predictive. Comparison with stress testing and thallium
imaging using coronary angiography as the gold standard,
however, shows little difference in predictability of coronary
stenosis; in fact the best results in direct comparison have
been with the latter. However, the data are inadequate. Four
studies referred to above are based on a total of 811
patients, only approximately half of whom had significant
angiographic stenosis. EBCT carries a sensitivity of 85 -
100% and a specificity of 41 - 76%.'
For the patient with atypical chest pain, particularly in the
younger age group, or patients with some bar to good
electrocardiographic assessment (e.g. left bundle-branch
block, female gender), EBCT seems to have a definite place
at present.
There is a major difference between coronary artery
disease with calcification and coronary heart disease with
infarction and angina. EBCT as locally practised and
promoted efficiently plots the former. The high incidence of
coronary calcification in the general population" and the fact
that in any age group the prevalence of coronary calcium is
10 - 100 times the expected incidence of coronary heart
disease over a 10-year period, highlight this dilemma.' Over-
prediction of coronary heart disease is greater in the
younger than the older population, doubtless because of the
increasing incidence of coronary heart disease with age.
The 'research project' proposed by Or Nel for tracking the
development of coronary artery and heart disease in the
emerging black middle-class population is therefore both
fascinating and daunting, financially and in terms of the
duration of the study.
The question of payment for services by RAMS must
surely be resolved on the basis of a clear role for EBCT
above existing and efficient forms of investigation. These do
exist (for example atypical chest pain, a bar to the
performance of a diagnostic stress test, typical chest pain
with a negative stress test, etc.) Undoubtedly the indications
will increase with time and further knowledge. Invasive
coronary angiography will in the foreseeable future be the
only way in which revascularisation can be planned or
performed. Stress testing such as EBCT, echocardiography
and risk factor detection offer much to the patient if expertly
and appropriately applied. Promotion of large-volume EBCT
screening by means of broad public appeal has not had
endorsement by professional medical bodies. The question
of ownership of the facility will undoubtedly resolve in the
luture, pari passu with the interest, commitment and
expertise of the practitioner. It is obviously mandatory that
referrals for EBCT be via a qualified and informed
cardiologist at this stage.
EBCT is clearly an exciting and growing technique. It is
certainly not experimental, but its clinical applicability, like all
technologically based medicine, needs defining, and will in
the future need redefining as evidence accumulates. A set of
guidelines is in the process of prepublication review and
may shed light on where we are, what we should be doing,
and certainly what we should be paid for. It may also help
tell us where we are going; an exciting prospect that should
not and will not limit itself to the detection of coronary
calcification. In the meantime, prophylactic therapy should
be based on accepted techniques.
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